학술논문
252 Interim results of an open-label trial to evaluate elexacaftor-tezacaftorivacaftor in individuals with cystic fibrosis and an N1303K mutation who are not eligible for modulator treatment
Document Type
Abstract
Author
Source
In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S128-S128
Subject
Language
ISSN
1569-1993